[{"id":"57251181-5098-41ed-b023-ad42dab71405","acronym":"","url":"https://clinicaltrials.gov/study/NCT03000335","created_at":"2021-02-09T18:52:23.293Z","updated_at":"2024-07-02T16:37:03.224Z","phase":"","brief_title":"Evaluation of ProALL miRs in Blood Specimen for Prediction of ALL Relapse Risk","source_id_and_acronym":"NCT03000335","lead_sponsor":"Curewize Health Ltd.","biomarkers":" MIR1290","pipe":"","alterations":" ","tags":["MIR1290"],"overall_status":"Unknown status","enrollment":" Enrollment 65","initiation":"Initiation: 12/01/2016","start_date":" 12/01/2016","primary_txt":" Primary completion: 05/01/2020","primary_completion_date":" 05/01/2020","study_txt":" Completion: 12/01/2021","study_completion_date":" 12/01/2021","last_update_posted":"2019-02-04"}]